United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - piroxicam (unii: 13t4o6vmam) (piroxicam - unii:13t4o6vmam) - piroxicam 10 mg - feldene is indicated: feldene is contraindicated in the following patients: risk summary use of nsaids, including feldene, can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios and, in some cases, neonatal renal impairment. because of these risks, limit dose and duration of feldene use between about 20 and 30 weeks of gestation, and avoid feldene use at about 30 weeks of gestation and later in pregnancy (see clinical considerations, data ). premature closure of fetal ductus arteriosus use of nsaids, including feldene, at about 30 weeks gestation or later in pregnancy increases the risk of premature closure of the fetal ductus arteriosus. oligohydramnios/neonatal renal impairment use of nsaids at about 20 weeks gestation or later in pregnancy has been associated with cases of fetal renal dysfunction leading to oligohydramnios, and in some cases, neonatal renal impairment. data from observational studies regarding other potential embryofetal risks of n

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - piroxicam - gel - piroxicam 5 mg/g - piroxicam - piroxicam - variety of conditions characterized by pain and inflammation such as osteoarthritis of superficial joints, acute musculoskeletal injuries, periarthritis, tendinitis and tenosynovitis.

Ireland - English - HPRA (Health Products Regulatory Authority)

tillotts pharma gmbh - mesalazine - suppository - 1000 milligram(s) - mesalazine

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - piroxicam -

Canada - English - Health Canada

pfizer canada ulc - piroxicam - suppository - 10mg - piroxicam 10mg - other nonsteroidal antiimflammatory agents

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

pfizer pharmaceuticals inc. - piroxicam - white opaque rectal suppository, diameter : 8.5 to 11.5 mm, length : 29.0 mm

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - piroxicam -

United States - English - NLM (National Library of Medicine)

keltman pharmaceuticals inc. - piroxicam (unii: 13t4o6vmam) (piroxicam - unii:13t4o6vmam) - piroxicam 20 mg - carefully consider the potential benefits and risks of piroxicam capsules and other treatment options before deciding to use piroxicam capsules. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). piroxicam capsules are indicated: - for relief of the signs and symptoms of osteoarthritis. - for relief of the signs and symptoms of rheumatoid arthritis. piroxicam capsules are contraindicated in patients with known hypersensitivity to piroxicam. piroxicam capsules should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings , anaphylactoid reactions and precautions , preexisting asthma ). piroxicam capsules are contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings ).

Canada - English - Health Canada

pharmascience inc - piroxicam - suppository - 10mg - piroxicam 10mg - other nonsteroidal antiimflammatory agents

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer limited - piroxicam - gel - 5.0 mg/g - oxicams